A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
A team from the Research Institute of the McGill University Health Center (The Institute), led by Jean-Jacques Lebrun, Ph.D., ...
Morning Overview on MSN
Study finds internal cell fluid “trade winds” that aid movement and repair
Scientists at Oregon Health and Science University have discovered that cells generate steady internal fluid currents, dubbed ...
Bicara Therapeutics is well-capitalized, with over $414.8M in cash and funding runway into H1 2029, but faces competitive ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the ...
This phenomenon allows cancer cells to more easily spread. Courtesy of UC San Diego Health Sciences. Breast cancer frequently ...
Using a variety of laboratory and animal models, the team found that cysteine fuels the production of the antioxidant ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...
Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into ...
StudyFinds on MSN
Common blood pressure drug may boost a leading cancer therapy
In A Nutshell A common blood pressure drug, telmisartan, boosted the effectiveness of a cancer drug in lab and mouse studies.
Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...
Paras Gaur, a postdoctoral researcher at the University of Iowa, investigates DNA damage repair and G-quadruplex structures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results